Viewing Study NCT05076695


Ignite Creation Date: 2025-12-24 @ 2:05 PM
Ignite Modification Date: 2026-01-29 @ 9:12 AM
Study NCT ID: NCT05076695
Status: UNKNOWN
Last Update Posted: 2021-10-13
First Post: 2021-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Estrogen Receptor-positive Breast Cancer View
None HER2-positive Breast Cancer View
Keywords: